<DOC>
	<DOC>NCT01781520</DOC>
	<brief_summary>The purpose of this study is to evaluate the antitumor effect and safety of clinical effectiveness S-1 plus dendritic cell activated Cytokine induced killer treatment (DC-CIK) for unresectable locally advanced pancreatic cancer.</brief_summary>
	<brief_title>Study of S-1 Plus DC-CIK for Patients With Unresectable Locally Advanced Pancreatic Cancer</brief_title>
	<detailed_description />
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<criteria>Histologically or cytologically confirmed locally advanced, unresectable or metastatic adenocarcinoma of the pancreas not amenable to curative radiotherapy or surgery. Capable of oral intake Between 18 and 80 years old Measurable disease as defined by Response Evaluation Criteria in Solid Tumors (RECIST) criteria Karnofsky Performance Status (KPS) ≥ 70% Normal functions of heart, lung and bone marrow Adequate hematological profile： Hemoglobin ≥ 9.0 g/dL Absolute granulocyte count ≥ 1,500/mm3 Platelet count ≥ 100,000/mm3 Adequate hepatic function Total bilirubin level≤ 3.0 times the upper limit of normal (ULN) Transaminases AST (SGOT) and ALT (SGPT) ≤ 2.5 times ULN Adequate renal function(normal serum creatinine level) A life expectancy≥ 2 months Informed consent signed Current enrollment in another clinical study with an investigational agent. Patients participating in surveys or observational studies are eligible to participate in this study Any radiotherapy or surgery within the previous 3 weeks Symptomatic brain metastasis not controlled by corticosteroids Bone marrow metastasis Active infection Serious complications Receiving a concomitant treatment with drugs interacting with S1. The following drugs are prohibited because there may be an interaction with S1: phenytoin, potassium warfarin , flucytosine, cimetidine and folinic acid. Pregnant or lactation women, or women with known or suspected pregnancy and men who want let to pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Pancreatic Cancer</keyword>
	<keyword>S1</keyword>
	<keyword>DC-CIK</keyword>
</DOC>